Aurora Spine Corporation
ASAPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $17,563 | $14,520 | $14,877 | $10,545 |
| % Growth | 21% | -2.4% | 41.1% | – |
| Cost of Goods Sold | $6,929 | $6,309 | $7,068 | $5,711 |
| Gross Profit | $10,634 | $8,211 | $7,810 | $4,834 |
| % Margin | 60.5% | 56.5% | 52.5% | 45.8% |
| R&D Expenses | $696 | $1,114 | $1,160 | $941 |
| G&A Expenses | $8,757 | $6,821 | $6,078 | $4,994 |
| SG&A Expenses | $9,569 | $7,543 | $7,124 | $5,794 |
| Sales & Mktg Exp. | $812 | $722 | $1,046 | $800 |
| Other Operating Expenses | $35 | $0 | $869 | $649 |
| Operating Expenses | $10,301 | $9,707 | $9,153 | $7,384 |
| Operating Income | $333 | -$1,495 | -$1,343 | -$2,550 |
| % Margin | 1.9% | -10.3% | -9% | -24.2% |
| Other Income/Exp. Net | -$1,288 | -$185 | -$158 | $191 |
| Pre-Tax Income | -$954 | -$1,681 | -$1,501 | -$2,359 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$954 | -$1,681 | -$1,564 | -$2,518 |
| % Margin | -5.4% | -11.6% | -10.5% | -23.9% |
| EPS | -0.012 | -0.024 | -0.023 | -0.043 |
| % Growth | 48.3% | -1.7% | 45.5% | – |
| EPS Diluted | -0.012 | -0.024 | -0.023 | -0.043 |
| Weighted Avg Shares Out | 77,592 | 70,669 | 66,797 | 58,707 |
| Weighted Avg Shares Out Dil | 77,592 | 70,669 | 66,797 | 58,707 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $167 | $185 | $164 | $158 |
| Depreciation & Amortization | $959 | $1,049 | $834 | $643 |
| EBITDA | $171 | -$446 | -$504 | -$1,557 |
| % Margin | 1% | -3.1% | -3.4% | -14.8% |